Canine Influenza Treatment Market 2028 By : Type, Distribution Channel, and Geography | The Insight Partners

Canine Influenza Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by : Type (Antibiotics, Nonsteroidal anti-inflammatory Drugs (NSAIDs), Antiviral Drugs, and Others); Distribution Channel (Veterinary Clinics, Veterinary Pharmacies, Online Pharmacies, and Others), and Geography

Report Code: TIPRE00022898 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW

Canine influenza is also called dog flu. It is an infectious respiratory disease that spreads in an airborne and aerosolized manner in dogs, caused by Type A influenza viruses. So far, no human infections with canine influenza have been reported. Canine influenza is done in two segments are H3N8 virus and the H3N2 (seasonal influenza A) virus. Canine influenza of H3N8 viruses done in horses spread to dogs and spread among dogs. The canine influenza H3N8 virus was first reported in 2004 in the U.S. Canine influenza of H3N2 viruses observed in birds spread to dogs and spread among dogs.

MARKET SCOPE

The "Global Canine Influenza Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the canine influenza treatment market with detailed market segmentation by type, distribution channel, and geography. The report provides key statistics on the market status of the leading canine influenza treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global canine influenza treatment market is segmented into antibiotics, nonsteroidal anti-inflammatory drugs (nsaids), antiviral drugs, others.
  •  On the basis of distribution channel, the market is segmented into veterinary clinics, veterinary pharmacies, online pharmacies, others.

MARKET DYNAMICS
Drivers

  •  Rise in the incidences of Canine Influenza.
  •  Lower cost of procedure as compared to conventional methods.
  •  Growing pet adoptions globally.
  •  Rise in FDA and research institutes.

Restraints

  •  The limited numbers of vaccine are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The canine influenza treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the canine influenza treatment market in these regions.

IMPACT OF COVID-19 ON CANINE INFLUENZA TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the canine influenza treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from canine influenza treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for canine influenza treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the canine influenza treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Merck Animal Health
  •  Pfizer
  •  Sanofi
  •  Zoetis
  •  Novartis
  •  Bristol-Myers Squibb
  •  Eli Lilly and Company
  •  Boehringer Ingelheim International
  •  Roche
  •  GlaxoSmithKline

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. Merck Animal Health
2. Pfizer
3. Sanofi
4. Zoetis
5. Novartis
6. Bristol-Myers Squibb
7. Eli Lilly and Company
8. Boehringer Ingelheim International
9. Roche
10. GlaxoSmithKline
TIPRE00022898
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount